Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hartvig

Showing results (161-170 of 249) with videos related to

Pageof 25
Sort By:
Journal of Chromatography. B, Biomedical Applications|April 26, 1996
Analysis of L-[methyl-11C]methionine and metabolites in human plasma by an automated solid-phase extraction and a high-performance liquid chromatographic procedureK J Lindner, P Hartvig, C Akesson, et al.
Lakartidningen|October 30, 1996
[Safer drug handling in hospitals. A new task for the drug committee]P O Osterman, L Gyllenspetz, P Hartvig, et al.
Developmental Pharmacology and Therapeutics|January 1, 1989
Positron emission tomography in studies on fetomaternal disposition of opioidsP Hartvig, B S Lindberg, A Lilja, et al.
European Journal of Clinical Pharmacology|November 1, 1980
Pharmacokinetics and oral bioavailability of pyridostigmine in manS M Aquilonius, S A Eckernäs, P Hartvig, et al.
Neurology|May 1, 1996
Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PETJ Tedroff, M Pedersen, S M Aquilonius, et al.
Acta Neurologica Scandinavica|March 1, 1992
Estimation of regional cerebral utilization of [11C]-L-3,4-dihydroxy-phenylalanine (DOPA) in the primate by positron emission tomographyJ Tedroff, S M Aquilonius, P Hartvig, et al.
Pharmacology & Toxicology|April 1, 1989
Characterization of the antinociception induced by intrathecally administered carbacholP G Gillberg, T Gordh, P Hartvig, et al.
Acta Neurologica Scandinavica|February 1, 1992
Cerebral uptake and utilization of therapeutic [beta-11C]-L-DOPA in Parkinson's disease measured by positron emission tomography. Relations to motor responseJ Tedroff, S M Aquilonius, P Hartvig, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 1, 1995
Liquid chromatographic analysis of brain homogenates and microdialysates for the quantification of L-[beta-11C]DOPA and its metabolites for the validation of positron emission tomography studiesK J Lindner, P Hartvig, J Tedroff, et al.
Journal of Neural Transmission. General Section|January 1, 1992
Regional brain kinetics of 6-fluoro-(beta-11C)-L-dopa and (beta-11C)-L-dopa following COMT inhibition. A study in vivo using positron emission tomographyP Hartvig, K J Lindner, J Tedroff, et al.
Pageof 25

Showing results (161-170 of 249) with videos related to

Sort By:
Pageof 25
Journal of Chromatography. B, Biomedical Applications|April 26, 1996
Analysis of L-[methyl-11C]methionine and metabolites in human plasma by an automated solid-phase extraction and a high-performance liquid chromatographic procedureK J Lindner, P Hartvig, C Akesson, et al.
Lakartidningen|October 30, 1996
[Safer drug handling in hospitals. A new task for the drug committee]P O Osterman, L Gyllenspetz, P Hartvig, et al.
Developmental Pharmacology and Therapeutics|January 1, 1989
Positron emission tomography in studies on fetomaternal disposition of opioidsP Hartvig, B S Lindberg, A Lilja, et al.
European Journal of Clinical Pharmacology|November 1, 1980
Pharmacokinetics and oral bioavailability of pyridostigmine in manS M Aquilonius, S A Eckernäs, P Hartvig, et al.
Neurology|May 1, 1996
Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PETJ Tedroff, M Pedersen, S M Aquilonius, et al.
Acta Neurologica Scandinavica|March 1, 1992
Estimation of regional cerebral utilization of [11C]-L-3,4-dihydroxy-phenylalanine (DOPA) in the primate by positron emission tomographyJ Tedroff, S M Aquilonius, P Hartvig, et al.
Pharmacology & Toxicology|April 1, 1989
Characterization of the antinociception induced by intrathecally administered carbacholP G Gillberg, T Gordh, P Hartvig, et al.
Acta Neurologica Scandinavica|February 1, 1992
Cerebral uptake and utilization of therapeutic [beta-11C]-L-DOPA in Parkinson's disease measured by positron emission tomography. Relations to motor responseJ Tedroff, S M Aquilonius, P Hartvig, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 1, 1995
Liquid chromatographic analysis of brain homogenates and microdialysates for the quantification of L-[beta-11C]DOPA and its metabolites for the validation of positron emission tomography studiesK J Lindner, P Hartvig, J Tedroff, et al.
Journal of Neural Transmission. General Section|January 1, 1992
Regional brain kinetics of 6-fluoro-(beta-11C)-L-dopa and (beta-11C)-L-dopa following COMT inhibition. A study in vivo using positron emission tomographyP Hartvig, K J Lindner, J Tedroff, et al.
Pageof 25